动态CTA评估血栓通透性可预测再灌注治疗后的良好预后
本研究回顾性纳入104例大脑中动脉M1段闭塞的急性缺血性卒中患者,利用灌注CT衍生的26期动态CTA测量血栓衰减增加(TAI)以评估血栓通透性。结果显示TAImax、TAIpeak和TAIcon均与3个月良好预后独立相关,ROC曲线下面积分别为0.734、0.701和0.658。结论认为动态CTA评估的血栓通透性可能比常规单期CTA更好地预测再灌注治疗后的预后。
要点
- 动态CTA测量的血栓衰减增加最大值(TAImax)预测良好预后的AUC为0.734。
- TAImax、TAIpeak和TAIcon均与3个月良好预后独立相关(OR值分别为1.027、1.029、1.026)。
- 动态CTA评估血栓通透性可能优于常规单期CTA。
核心结论
- 动态CTA评估的血栓通透性可能比常规单期CTA更好地预测再灌注治疗后的预后。
研究设计与样本
- 回顾性队列研究,纳入104例大脑中动脉M1段闭塞且治疗前接受灌注CT的急性缺血性卒中患者,基于灌注CT衍生的26期动态CTA评估血栓通透性,以3个月mRS评分≤2定义为良好预后。
诊断标准与关键数值
- 血栓通透性以血栓衰减增加(TAI)表示;TAImax为各期TAI最大值,TAIpeak为动脉峰值期TAI,TAIcon为第13期TAI;TAImax、TAIpeak、TAIcon预测良好预后的AUC分别为0.734、0.701、0.658;TAImax的OR=1.027(95%CI 1.007-1.048,P=.008),TAIpeak的OR=1.029(95%CI 1.005-1.054,P=.020),TAIcon的OR=1.026(95%CI 1.002-1.051,P=.037);良好预后定义为3个月mRS评分≤2。
临床应用与阅片要点
- 作者认为动态CTA评估的血栓通透性可能比常规单期CTA更好地预测再灌注治疗后的预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Thrombus permeability assessed on conventional CTA is associated with neurologic outcome in patients with acute ischemic stroke. We aimed to investigate whether dynamic CTA can improve the accuracy of thrombus permeability assessment and its predictive value for outcome.
MATERIALS AND METHODS: We reviewed consecutive patients with acute ischemic stroke who had occlusion of the M1 segment of the middle artery cerebral artery and underwent pretreatment perfusion CT. Thrombus permeability, determined by thrombus attenuation increase (TAI), was assessed on 26-phase dynamic CTA derived from perfusion CT. TAImax was defined as the maximum TAI among phases; TAIpeak, as TAI of peak arterial phase; TAIcon, as TAI on phase 13. Good outcome was defined as a 3-month mRS score of ≤2.
RESULTS: One hundred four patients were enrolled in the final analysis. The median TAImax, TAIpeak, and TAIcon were 30.1 HU (interquartile range, 13.0-50.2 HU), 9.5 HU (interquartile range, -1.6-28.7 HU), and 6.6 HU (interquartile range, -5.1-24.4 HU), respectively. Multivariable regression analyses showed that TAImax (OR = 1.027; 95% CI, 1.007-1.048; P = .008), TAIpeak (OR = 1.029; 95% CI, 1.005-1.054; P = .020), and TAIcon (OR = 1.026; 95% CI, 1.002-1.051; P = .037) were independently associated with good outcome. The areas under the ROC curve of TAImax, TAIpeak, and TAIcon in predicting good outcome were 0.734, 0.701, and 0.658, respectively.
CONCLUSIONS: Thrombus permeability assessed on dynamic CTA could be a better predictor of outcome after reperfusion therapy than that assessed on conventional single-phase CTA.
引用
- Chen Z, Shi F, Gong X, et al. Thrombus Permeability on Dynamic CTA Predicts Good Outcome after Reperfusion Therapy. AJNR Am J Neuroradiol. 2018. PMID: 30166435. doi:10.3174/ajnr.A5785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。